Articles

More research shows the disease may one day be reversible.

Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab.

Three paragraphs in a 1994 letter to Berkshire Hathaway shareholders reveal the top reason for Buffett’s phenomenal winning record.

Here’s a rundown of what retirees and savers can expect in the coming year.

As we greet 2026, be prepared for some holiday closures.

Everyone — no matter their wealth level — can benefit from some financial maintenance.

Although the S&P 500 has returned 19.3% so far this year, dozens of stocks are showing significant declines for 2025.

Lululemon founder and large shareholder Chip Wilson is looking to restore investor faith in the yoga-gear maker by changing the makeup of the board of directors.

AI tools are more powerful than ever, but they’re creating an internet flooded with low-quality content

“She is an intelligent and responsible individual.”

Alphabet took the title as this year’s top-performing ‘Magnificent Seven’ stock, but the AI competition is fierce

These 10 ideas targeting affordability will be tested in 2026. A look at the ones that could help most, including Trump accounts, free child care and tariff checks.